Together, our data suggests that iNOS overexpression in tumor cells sensitizes them to low-dose L-DOX therapy, contributing to the enhanced survival of animals receiving iNOS transfection in conjunction with low doses of L-DOX. Here, NOS2 is linked to neoplasm.